The global Placental Stem Cell Therapy market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 5.1 Billion by the end of 2030. The global Placental Stem Cell Therapy market is estimated to expand at a modest CAGR of 20.3% during the prediction period 2021 to 2030.
The placenta is an organ that connects the developing fetus to the uterine wall, enabling a flow of nutrients, gases, and hormones between the mother and the fetus during pregnancy. After childbirth, blood remains in the placenta, which can be collected and stored for a fee, for future therapeutic use. The human extra-embryonic tissues (placenta, amniotic membranes, and umbilical cord) as well as human placental fluids (amniotic fluid and umbilical cord blood) were also defined as sources of Mesenchymal stem cells (MSCs), which represents a great interest for biomedical applications. Immunomodulatory properties of human placenta as well as the clinical applicability of such placental parts as amniotic membranes for wound healing, treatment of burns, and reconstruction of the oral cavity are expected to drive its demand.
In terms of application, the global placental stem cell therapy market has been divided into hematologic malignancies and disorders, congenital immunodeficiency disorders, metabolic disorders, neurological disorders, and others. The neurological disorders segment held a significant share of the global placental stem cell therapy market in 2020. Based on end user, the global placental stem cell therapy market has been split into hospitals & specialty clinics, clinical research organizations, and research institutes & academies. The clinical research organizations segment held a significant share of the global placental stem cell therapy market in 2020.
This research report purposes at stressing the most lucrative growth prospects.The aim of the research report is to provide an inclusive valuation of the Placental Stem Cell Therapy market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Placental Stem Cell Therapy market reportaids in comprehendingmarket structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The placental mesenchymal stem cells therapy is gaining popularity as a potential solution for the treatment of severe COVID-19. The Institute of Cell Therapy is acquiring recognition for successfully curing COVID-19 patients with the help of placental stem cells lacking ACE-2 receptor, which hold promising potentials in the treatment of coronavirus pneumonia. As such, worldwide inoculation of coronavirus vaccines from India has caused a slowdown in research activities of the placental stem cell therapy market.
The report comprises the scrutiny of COVID-19 lock-downimpact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilaracross various industry verticals. The research reportofferspresent short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lastingtactics for recovery and by region.
Placental Stem Cell Therapy market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplish sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share.Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Placental Stem Cell Therapy Market are:
The global placental stem cell therapy market include Lifebank Stem Cell Banking, Celularity, Inc., Americord Registry, ReeLabs Pvt. Ltd., Pluristem Therapeutics, Inc., Mesoblast Limited, ReNeuron Group plc, and Athersys, Inc.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects includingproduct type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2030 and covers subsequent region in its scope:
Global Placental Stem Cell Therapy Market: Segmentation
Placental Stem Cell Therapy Market, by Application
- Hematologic Malignancies and Disorders
- Congenital Immunodeficiency Disorders
- Metabolic Disorders
- Neurological Disorders
- Others
Placental Stem Cell Therapy Market, by End User
- Hospitals & Specialty Clinics
- Clinical Research Organizations
- Research Institutes & Academies
By Regional Outlook
North America
Europe
- Germany
- United Kingdom
- Italy
- France
- Rest of EU
Asia Pacific
- China
- India
- Japan
- Southeast Asia
- Rest of APAC
Central & South America
- Brazil
- Argentina
- Rest of Central & South America
Middle East and Africa
- GCC
- North Africa
- South Africa
Request Customization
Get a Sample
Get a Sample
Request Customization